CSF2 and autoimmune pulmonary alveolar proteinosis: We found that (i) patients with autoimmune PAP tended to have higher levels of anti GM-CSF autoantibodies, (ii) levels and global neutralizing activity of plasma correlated, and (iii) there was no significant difference between groups in terms of neutralizing activity of anti-GM-CSF autoantibodies.